Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Net Margin: 2010-2016

Historic Net Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to 2,246,578.63%.

  • Tenax Therapeutics' Net Margin was N/A to 2,246,578.63% in Q4 2016 from the same period last year, while for Dec 2016 it was 611.65%, marking a year-over-year change of. This contributed to the annual value of 76,534.78% for FY2024, which is 4414312.00% up from last year.
  • As of Q4 2016, Tenax Therapeutics' Net Margin stood at 2,246,578.63%, which was up 31,622.42% from 7,081.99% recorded in Q2 2013.
  • Tenax Therapeutics' 5-year Net Margin high stood at 2,246,578.63% for Q4 2016, and its period low was -4,866.90% during Q1 2012.
  • Its 1-year average for Net Margin is 2,246,578.63%, with a median of 2,246,578.63% in 2016.
  • Examining YoY changes over the last 5 years, Tenax Therapeutics' Net Margin showed a top increase of 1,019,043bps in 2012 and a maximum decrease of 1,538,948bps in 2012.
  • Tenax Therapeutics' Net Margin (Quarterly) stood at -301.12% in 2012, then spiked by 983,275bps to 7,081.99% in 2013, then reached 2,246,578.63% in 2016.
  • Its Net Margin was 2,246,578.63% in Q4 2016, compared to 7,081.99% in Q2 2013 and -1,085.17% in Q1 2013.